RECOMBINANT THERAPEUTIC GLYCINE N-ACYLTRANSFERASE
    11.
    发明申请
    RECOMBINANT THERAPEUTIC GLYCINE N-ACYLTRANSFERASE 审中-公开
    重组治疗糖蛋白N-酰基转移酶

    公开(公告)号:US20130224175A1

    公开(公告)日:2013-08-29

    申请号:US13818481

    申请日:2011-08-24

    CPC classification number: C12N9/1029 C12P21/02 C12Y203/01013

    Abstract: This invention relates to a method of producing a recombinant enzyme, more particularly, this invention relates to a method of producing water soluble enzymatically active recombinant glycine N-acyltransferase (GLYAT (E.G. 2.1.3.13)), including the steps of providing a suitable expression host; preparing a vector including a gene for expressing GLYAT in the expression host to form an expression piasmid; transforming the host with the expression piasmid to form an expression system; expressing the GLYAT gene in the expression system; and separating the expressed GLYAT from the expression system.

    Abstract translation: 本发明涉及一种生产重组酶的方法,更具体地说,本发明涉及一种生产水溶性酶活性重组甘氨酸N-酰基转移酶(GLYAT(EG2.1.3.13))的方法,包括提供合适表达的步骤 主办; 制备包含用于在表达宿主中表达GLYAT的基因以形成表达piasmid的载体; 用表达式piasmid转换主机以形成表达系统; 在表达系统中表达GLYAT基因; 并将表达的GLYAT与表达系统分离。

Patent Agency Ranking